Differential flt3 mutational status in acute myeloid leukemia predicts sensitivity to flt3 inhibitor gilteritinib in vitro and in vivo

被引：0
|
作者：
John, Bincy
Sundaramoorthy, Pasupathi
Rainbolt, Elizabeth
Wong, Andrew
Ward, Zachary
Avery, Justin
Todd, Savannah
Kidder, Shasta
Gietl, Diana
Hall, Chassidy
Harris, David
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
    Juanjuan Zhao
    Yongping Song
    Delong Liu
    [J]. Biomarker Research, 7
  • [2] Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
    Masamichi Mori
    Naoki Kaneko
    Yoko Ueno
    Masaki Yamada
    Ruriko Tanaka
    Rika Saito
    Itsuro Shimada
    Kenichi Mori
    Sadao Kuromitsu
    [J]. Investigational New Drugs, 2017, 35 : 556 - 565
  • [3] Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
    Mori, Masamichi
    Kaneko, Naoki
    Ueno, Yoko
    Yamada, Masaki
    Tanaka, Ruriko
    Saito, Rika
    Shimada, Itsuro
    Mori, Kenichi
    Kuromitsu, Sadao
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 556 - 565
  • [4] FLT3 mutational analysis in acute myeloid leukemia
    Gari, Mamdooh
    Abuzenadah, Adel
    Chaudhary, Adeel
    Qahtani, Mohammed
    Al-Sayes, Fatin
    Damanhouri, Ghazi
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 106 - 106
  • [5] The importance of FLT3 mutational analysis in acute myeloid leukemia
    Patnaik, Mrinal M.
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (10) : 2273 - 2286
  • [6] Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
    Numan, Yazan
    Abdel Rahman, Zaid
    Grenet, Justin
    Boisclair, Stephanie
    Bewersdorf, Jan Philipp
    Collins, Cailin
    Barth, Dylan
    Fraga, Martina
    Bixby, Dale L.
    Zeidan, Amer M.
    Yilmaz, Musa
    Desai, Pankil
    Mannis, Gabriel
    Deutsch, Yehuda E.
    Abaza, Yasmin
    Dinner, Shira
    Frankfurt, Olga
    Litzow, Mark
    Al-Kali, Aref
    Foran, James M.
    Sproat, Lisa Z.
    Jovanovic, Borko
    Daver, Naval
    Perl, Alexander E.
    Altman, Jessica K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : 322 - 328
  • [7] Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia (vol 7, 19, 2019)
    Zhao, Juanjuan
    Song, Yongping
    Liu, Delong
    [J]. BIOMARKER RESEARCH, 2019, 7 (01)
  • [8] Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
    Zhang, Yvyin
    Wang, Peihong
    Wang, Yang
    Shen, Yang
    [J]. BIOMARKER RESEARCH, 2023, 11 (01)
  • [9] Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
    Yvyin Zhang
    Peihong Wang
    Yang Wang
    Yang Shen
    [J]. Biomarker Research, 11
  • [10] Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation
    Chew, Serena
    Mackey, Melissa C.
    Jabbour, Elias
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
12345